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Preeclampsia is among the three leading causes of maternal mortality and morbidity 
worldwide, occurs in 6-8% of all pregnancies, and is estimated to account for at least nine 
percent of maternal deaths in Africa. Studies from developed countries show that high 
prepregnancy BMI increases the risk of preeclampsia. We examined the association of 
prepregnancy body mass index and changes of prepregnancy body weight between 
pregnancies with risk of preeclampsia in the second pregnancy. In the term preeclampsia we 
also include cases of eclampsia.  
Method 
A historic registry based study was used, analysing births registered in the Kilimanjaro 
Christian Medical Center (KCMC) birth registry between July 2000 and May 2013. Two sets 
of data were analysed; singleton births of gravida 1 or 2 mothers (n= 17, 750 births), and the 
linked first two recorded singleton births to a woman, irrespective of gravidity (n =3, 595 
mothers). Prepregnancy BMI was categorized according to WHO categories underweight 
(less than 18.5), normal (18.5 – 24.9), overweight (25.0 – 29.9) and obese (30 or greater). 
Measured confounders were adjusted for in multivariable models. 
Results 
Among the 17,750 singleton births, 9.1 % of the mothers were underweight, 24.0 % were 
overweight, and 7.4 % were obese.  Five hundred and eighty-two pregnancies (3.3 %) were 
affected by preeclampsia. Compared to women of normal BMI, overweight and obese women 
had an increased risk of preeclampsia (AOR 1.5 (95%CI 1.2 – 1.7 and, 1.7(1.2 – 2.1), 
respectively, while underweight was protective (AOR 0.8 (0.8 - 1.1). Among 3,595 mothers 
without preeclampsia in their first recorded pregnancy, incidence of preeclampsia was 2% in 
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the second recorded pregnancy. Weight loss, but not weight gain between the pregnancies was 
associated with risk of preeclampsia in the last pregnancy. The effect of weight change did 
not change after adjustment for BMI in second pregnancy. 
 Conclusion 
The association between prepregnancy body mass index and preeclampsia in this population 
of pregnant women in Northern Tanzania corresponds with earlier findings from developed 
countries. Overweight and obesity should be considered an obstetric risk factor is this 
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1.0 General introduction 
Definition of preeclampsia and eclampsia 
Hypertension is defined as systolic blood pressure ≥140 mm Hg or diastolic blood pressure 
≥90 mm Hg; or systolic blood pressure increase of ≥30 mm Hg or diastolic blood pressure 
increase of ≥15 mm Hg [1]. Pre-eclampsia is defined as hypertension accompanied by 
proteinuria first detected after 20 weeks of gestation. Proteinuria is defined as at least 300 mg 
protein in a 24 hour urine collection (or ≥ 1 + dipstick (30 mg/dL) in a single urine sample 
[2]. Preeclampsia can further be defined as mild or severe; mild preeclampsia defined as 
elevated blood pressure of  systolic blood pressure of  >140mm Hg or diastolic blood pressure 
> 90 mmHg taken 6 hours apart  combined with protenuria of 300 mg from a 24 hours urine 
collection [3]. Severe preeclampsia defined as more elevated blood pressure accompanied 
with end organ damage [3].  Preeclampsia may develop into a more severe condition called 
eclampsia. Eclampsia refers to the development of grand mal seizures in a woman with 
gestational hypertension or preeclampsia [4]. The seizures can occur before delivery, during, or 
after labor. It is a serious condition that is associated with increased risk of mortality and 
morbidity in the pregnant women and poor perinatal outcomes. For the developing countries the 
mortality associated with this manifestation is as high as 15% [4].  
Classification of hypertensive disorders during pregnancy 
There are four levels of hypertensive disorders during pregnancy, defined by blood pressure, 
proteinuria and severity of symptoms: Gestational hypertension/ pregnancy induced 
hypertension defined as systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 
mm Hg diagnosed for the first time after 20 weeks' gestation, in the absence of proteinuria 
and resolves within three months post-delivery [5]. Preeclampsia defined as systolic blood 
pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg diagnosed for the first time 
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after 20 weeks' gestation, accompanied by proteinuria. Preeclampsia can be mild without 
proteinuria and symptoms of severity and can be severe with blood pressure of equal or more 
than 160/110mm Hg with or without proteinuria. Eclampsia is the occurrence of grand mal 
seizures occurred as a complication of pre-eclampsia [5]. Chronic hypertension defined as 
hypertension diagnosed before 20 weeks of gestation or having hypertension before present 
pregnancy which can be with no underlying causes or with underlying disease. Superimposed 
preeclampsia defined as having higher blood pressure than before pregnancy in a known 
chronic hypertensive women followed by significant or worsening proteinuria (with or 
without symptoms of severity) [5]. 
Signs and symptoms of preeclampsia 
These include high blood pressure and presence of protein in the urine, epigastric pain, 
vomiting, sudden severe swelling of hands, face or feet, and hyperreflexia. Laboratory 
abnormalities may include hemolysis, elevated liver enzymes, low platelet counts (HELLP 
syndrome) and increased of serum creatinine [6]. Some women may present with convulsions, 
abdominal pain or general malaise.  Headache and visual disturbances are the signs of central 
nervous system involvement [7].  
Risk factors 
Risk factors for preeclampsia have been well documented [8-10]. These include nulliparous, 
advanced maternal age, race other than white, high body mass index (BMI), chronic 
hypertension, diabetes (I/II), previous preeclampsia, previous intrauterine growth restriction 
(IUGR), previous abruption of placenta, long time since previous pregnancy, multiple 
pregnancy and triplet gestation, change in paternity from previous pregnancy, systemic 
inflammation and preexisting hypertension, diabetes mellitus, insulin resistance and renal 




Etiology of preeclampsia 
The pathogenesis of preeclampsia is still unknown, but genetic, immunologic, and 
environmental factors have been reported to be involved in the etiology, either separately or 
by interacting. Some studies have reported that preeclampsia is a two-stage disease that 
includes abnormal placentation [11]. The first stage is without symptoms where placenta 
insufficiency occurs as a result of development of abnormal placenta during the first trimester, 
and this is accompanied by release of excessive amounts of placental materials into the 
maternal circulation. This is followed by second stage which includes symptoms where in the 
pregnant woman develops characteristic hypertension, renal impairment, and proteinuria and 
is at risk for the HELLP syndrome (hemolysis, elevated liver function enzymes and low 
platelets), eclampsia, and other end-organ damage.   
Preeclampsia detection and prevention 
Early detection is necessary to prevent severe damage to the woman and the fetus and to 
prepare for a safe delivery. In developed countries, the procedures for detection of 
preeclampsia are well elaborated. However, most clinical and laboratory tests reported to be 
useful in the early detection of preeclampsia remain unrealistic and cost-effective particularly 
in developing countries [12]. Uterine Doppler artery and maternal serum makers have been 
reported to show promise in the early detection of preeclampsia, but there is not enough 
evidence to support their clinical use in poor resource settings [13]. Aspirin therapy used as 
prophylaxis was reported to be beneficial in decreasing preeclampsia in the specific 
population and to recommend its widespread needs more research [14, 15]. Similarly calcium 
supplementation was recommended to be used to those with highest risk and women who 
needs calcium supplementation [15, 16]. Vitamins supplementation, commonly C and E, was 
disproved by WHO studies [17] 
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Complications of preeclampsia 
Preeclampsia is associated with several maternal complications which include eclampsia, 
ischemic or hemorrhagic stroke, hemolysis, liver damage, and thrombocytopenia (HELLP 
syndrome with or without hemorrhage), disseminated intravascular coagulation, liver 
hemorrhage/rupture, pulmonary edema, adult respiratory distress syndrome, acute renal 
failure and death [4].  
Treatment and management of preeclampsia 
Management of preeclampsia mainly involves either delivery or observation depending on 
gestational age and severity of the syndrome. Studies have shown that delivery of the baby 
and placenta is the only cure, but the maternal and fetal risks have to be balanced. Delivery 
can be good for the safety of the mother but not for the very premature baby [18]. Decision on 
delivery and expectant management should be based on the assessment of fetal gestational 
age, fetal status and maternal condition. Close observation can be appropriate to women with 
mild preeclampsia and gestational age below 34 weeks [19]. A policy of expectant 
management can be applied in the management of severe preeclampsia with viable fetus and 
gestational age below 34 weeks with close monitoring of uncontrolled high blood pressure, 
increased maternal organ dysfunction and signs of fetal development [19]. On the other hand 
prolonged gestational age with severe preeclampsia can lead to fetal death or asphyxia and 
increased risk of maternal death [18]. Similarly, women with eclamptic seizures should be 
stabilized first using magnesium sulphate followed by delivery in a timely manner [19]. 
Antihypertensive drugs can be used as well to lower the blood pressure and prevent fetal 
bradycardia. Corticosteroids for lung maturation and magnesium sulphate for prevention of 
seizures can be administered to women with severe preeclampsia or eclampsia [18]. Mode of 
delivery for preeclamptic women should depend on fetal gestation age and condition, fetal 
presentation, presence of labour, and bishop score of the cervix [18]. Management during 
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labour and delivery should aim at prevention of seizures or eclampsia and control of 
hypertension, and women should be monitored up to 24 hours post-delivery [18].  
Limitations in the management of preeclampsia 
Studies have shown that proper management of preeclampsia depends on functional health 
systems which provide timely access to health care. This is in contrast to most of the 
developing countries in Sub-Saharan Africa including Tanzania, where access to health have 
been documented to be limited by a number of reasons,  as described  in the “Three Delays 
Model” [20-22]. First, delay in the decision to seek care in which a woman lacks proper 
information of when to seek help and where she can get help [23]. This has been reported to 
be associated with social demographic factors including lack of knowledge, single mothers 
and marital status [24]. Increasing user fee, poverty and lack of decision making have shown 
to worsen the situation [25, 26]. Second, delay in reaching the health facility has been 
documented to be among the obstacles in decreasing maternal mortality rate in developing 
countries [20]. This includes transportation with poor infrastructure especially during rainy 
season and referral system in which those who lives in rural area are the most affected 
compared to their counterpart [22, 25]. Unequal distribution of health facilities which favour 
urban compared to rural is among the obstacles [21, 22]. Third, delay in the provision of 
health services which can be contributed to a number of factors including shortage of health 
care providers, lack of drugs and incompetent staff who can sometime fail to administer some 








1.1 Global burden of preeclampsia 
Eight hundred women die every day from pregnancy or child birth related complications 
worldwide [27].  Approximately 10 -20 million women will experience complications 
associated with child bearing each year [26]. Ninety nine percent of these deaths occur in 
developing countries [27]. The differences in numbers of maternal deaths in parts of the world 
reflect inequities to access of health services and the gap between rich and poor [26]. In 
developing countries the maternal mortality ratio is 240 per 100,000 compared to 16 per 
100,000 in developed countries [27]. There are large disparities between countries, within 
countries, people with low and high income and between rural and urban areas [28]. 
Approximately 80% of maternal deaths are contributed by direct causes which include severe 
bleeding mostly after birth, infections commonly post-delivery, hypertensive disorders during 
pregnancy including preeclampsia, and unsafe abortion. The remaining 20% are due to 
previous existing disease like malaria. 
 
Worldwide, 10-15% of direct causes of maternal death are estimated to be due to 
preeclampsia [29].  Preeclampsia is among the 3 leading causes of maternal mortality and 
morbidity worldwide, occurs in 6-8% of all pregnancies and accounting for at least 9.1% of 
maternal death in Africa [30]. Worldwide, it is approximated that over 4 million women will 
develop hypertensive disorders during pregnancy every year, in which 50.000-100.000 
women will die from preeclampsia each year, and the disorder will be responsible for 
approximately 300.000 perinatal deaths [27, 31].  
1.2 Maternal mortality in developing countries 
Sub-Saharan Africa is responsible for 50% of all the maternal deaths globally [32], of which 
70% – 80 % are associated with direct causes which include complications of pregnancy, 
delivery, labour and postpartum period [30]. In Sub-Saharan Africa case fatality related to 
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pregnancy induced hypertensive disorders has been reported to range from 3% to 23% [22].  
In resource limited settings where early diagnosis and obstetric management are deficient, 
preeclampsia can be the leading cause of maternal and fetal morbidity and mortality [33, 34]. 
Worldwide, the incidence of preeclampsia is estimated to range from 2% to 10 % [31]. In 
developing countries the reported prevalence of preeclampsia ranges from 1.8% to 16.7% 
[20]. The wide variation in reported prevalence likely reflects variations in data collection or 
study design. The majority of maternal deaths are preventable [27]. Most of these deaths are 
due to lack of prenatal care, lack of access to hospital care, lack of resources, inappropriate 
diagnosis and poor management [29]. The focus of millennium development goal number five 
is to reduce maternal mortality by three quarters by 2015. This has been a challenge for 
developing countries in which maternal mortality is 100-200 higher than in developed 
countries [29]. Preeclampsia has been reported to increase the number of maternal deaths by 
1.8% in developed countries and by 14% in developing countries [35].  
1.3 Maternal deaths in Tanzania 
Tanzania has been reported to be among the countries with higher maternal mortality rate 
with a challenge of meeting fifth millennium development goal in 2015 [27]. Despite a high 
coverage of women who attended at least one ANC visit [36], Tanzania had been in a two 
different trends of maternal mortality ratio, from 1961 to 2010 [21]. After independence 1961 
to 1990 maternal mortality ratio had a downward trend from 453 to 200 per 100,000 live 
births, and again increased up to 578 per 100,000 live births from 1990. However, from 2010 
maternal mortality ratio in Tanzania has remained 454 deaths per 100,000 live births [21]. A 
woman dies almost every hour from maternal causes in Tanzania [27]. 
1.4 Preeclampsia in Tanzania 
Preeclampsia and associated complications have been reported to be among the main causes 
of maternal deaths in Tanzania. A study conducted in Dar es Salaam found eclampsia as a 
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complication from preeclampsia accounted for 12 % of all maternal deaths and was the third 
most common cause after haemorrhage and abortion [36]. The case fatality rate for 
hypertensive disorders during pregnancy including eclampsia in different populations among 
Tanzanian has been reported to range from 5%  to 7.8% [36, 37], in contrast to a case fatality 
rate of 1% or less in high income countries [29].  A study at KCMC on maternal deaths 
conducted with data from medical birth registry from 2000 – 2007 found a maternal mortality 
ratio of 550/100,000, and hypertensive disorders during pregnancy was reported to be the 
leading cause contributing to 41 out of the 119 deaths [38]. 
1.5 Preeclampsia and obesity 
The risk of preeclampsia increases with increasing pre-pregnancy body mass index (BMI) 
[10, 39]. BMI is widely accepted as a measure of both overweight and underweight. The 
World Health Organization classifies BMI into four categories, namely: underweight 16-
18.5kg/m2, normal 18.5-25kg/m2, overweight 25–29.9 kg/m2 and obese > 30 kg/m2. In many 
populations, prevalence of obesity among the pregnant population has been reported to 
increase significantly over the last decade. This has negative effects on many aspects of 
female reproductive life included preeclampsia [40]. Also increase in prepregnancy BMI from 
one pregnancy to a next pregnancy has been reported to increase the risk of preeclampsia 
[41]. Moreover, weight gain beyond normal during pregnancy is associated with an increased 
risk of pre-eclampsia in the subsequent pregnancy [8]. 
 
 Overweight and obesity in pregnancy have also been associated with an increased risk of 
other maternal complications such as gestational hypertension, macrosomia, induction of 
labour and caesarean delivery as well as an increased risk of neonatal complications [42]. On 
the other hand, underweight increases the risk of preterm delivery, low birth weight and 
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anaemia, but lowers the risk of pre-eclampsia, gestational diabetes, obstetric intervention and 
post-partum hemorrhage [42]. 
Obesity is a serious global public health problem and has consequences for nearly all areas of 
medicine. Obesity has been reported to increase the risk of preeclampsia about 3 fold [43] and 
is the leading identified attributable risk for this disorder. In obstetrics, obesity not only has a 
direct implication on the health of a pregnant woman but also on the offspring’s weight 
during infancy and beyond. As such, maternal weight may influence the prevalence and 
severity of obesity in future generations [44]. Pregnancy has been identified as a key time to 
target a weight control or weight loss strategy to help curb the rapidly growing obesity 
epidemic [45].  
1.6 Obesity in Tanzania 
Also the prevalence of obesity among women of reproductive age in Tanzania has been 
increasing significantly during the last decades [46]. The Tanzania demographic health survey 
(TDHS) conducted in 2010 found the overall prevalence of overweight and obesity among 
women of reproductive age has increased from 18% and 4% in year 2004/2005 to  21.1%  and 
6.1% in year 2010, respectively [46, 47]. Another population based study from Dar Es 
Salaam, Tanzania, showed that the prevalence of obesity  has increased from 3.6% to 9.1% 
among women of reproductive age between 1995 and 2004  [48]. Compared to other regions 
in Tanzania, overweight and obesity among women of reproductive age in Kilimanjaro has 
been reported to be even higher 24.1% and 10.8% respectively [46]. We were not able to 
identify more recent studies on prevalence of overweight and obesity in women of 






2.0 Statement of the problem and justification of the study 
Millennium development goal number five aims to reduce maternal deaths by three quarter by 
2015. The most efficient method for preventing maternal death is to focus on well-known 
preventable causes of maternal deaths, of which deaths due to preeclampsia are among the 
most important.  
At KCMC, hypertensive disorders during pregnancy including preeclampsia were reported to 
be a leading cause of maternal death. While obesity is an established risk factor for 
developing preeclampsia in developed countries, few studies from low and middle income 
countries have reported on obesity and pregnancy. Given the background of poverty and 
malnutrition among African women, the impact of pre-pregnancy BMI related with risk of 
pre-eclampsia may be of different from women in the high income countries. We aimed to 
examine the association of prepregnancy BMI and changes of prepregnancy BMI/body weight 
between pregnancies on the risk of preeclampsia in a population of pregnant women in 
Northern Tanzania. Dissemination of the findings from this study may give clinicians an 
overview of the health problems related to obesity and pregnancy induced hypertensive 











3.0 Study goal 
The main goal of this study is to contribute to the improvement of management of 
preeclampsia by examining the importance of prepregnancy BMI and changes in 
prepregnancy BMI/body weight between pregnancies in relation to preeclampsia. In our study 
we include eclampsia cases when we refer to the term preeclampsia.    
3.1 Study objectives 
Broad objective 
The general objective of this study is to investigate the effect of prepregnancy BMI and 
changes in prepregnancy BMI/body weight between pregnancies on risk of preeclampsia. 
Specific objective 
1. To compare maternal sociodemographic and obstetric characteristics according to pre-
pregnancy BMI categories in first and second pregnancy. 
2. To estimate the distribution of maternal characteristics in relation to preeclampsia in 
first and second pregnancy. 
3. To assess the effect of pre-pregnancy BMI on preeclampsia in the different BMI 
categories. 
4. To assess change in pre-pregnancy BMI/body weight between pregnancies on the risk 










Study setting, design and population 
Study setting 
According to the national census 2012 [49], Tanzania has 30 administrative regions divided 
into 169 districts. Kilimanjaro is one of the regions and is divided into 7 districts, namely 
Moshi rural, Moshi municipal (urban), Mwanga, Same, Hai, Siha, and Rombo. Kilimanjaro 
region lies in the northern part of Tanzania, boarded by Kenya in north and east, Tanga region 
in south, Manyara region in south-west and Arusha region in west.  
The population of Kilimanjaro region is approximately 1,640,000 people with 793,000 males 
and 846,000 females [49]. The Moshi municipal district had a population of 184,292, Moshi 
rural 466,737, Mwanga 131,442, Same 269,807, Hai 210,533, Siha 116,313 and Rombo 
260,963.  
The current study was conducted at Kilimanjaro Christian Medical Centre which is situated in 
Moshi municipal district. The Kilimanjaro Christian Medical Center (KCMC) is a private 
hospital. The two main ethnic groups in Kilimanjaro are Indigenous Chagga which is the third 
largest ethnic group in Tanzania and followed by Pare. There are also other small ethnic 
groups which have migrated to nearby Kilimanjaro such as the Kahe and Masai tribe. KCMC 
is one of the four zone referral hospitals in Tanzania. The hospital has different departments 
including obstetric department which receives women from the local communities as well as 
referred women from other regions. The hospital has 450 beds, and as a tertiary care hospital 
it serves a population of more than 11 million. The medical birth registry at KCMC was 
established in collaboration with researchers at the Department of Global Public Health and 
Primary Care (formerly Department of Public Health and Primary Health Care) at the 
University of Bergen Norway, and has been in operation since July 2000. 
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This hospital was chosen for this study because of the following reasons. (1) It is the only 
hospital in this region which has birth registry system. (2) Midwives from this hospital have 
been trained on how to conduct interviews using standard questionnare.  (3) It has been 
documented from previous studies that hypertensive disorders during pregnancy were the 
leading cause of maternal death in this hospital. 
Study design 
This is a registry based study using information singleton pregnancies to gravida one or two 
women whose data were collected at the time of each delivery. The data were prospectively 
collected by obstetricians and midwives from all women who delivered at Kilimanjaro 
Christian Medical Centre from July 2000 to May 2013. 
Study population 
Our source population included mothers who delivered at Kilimanjaro Christian Medical 
Centre (KCMC) from July 2000 to May 2013 and whose reproductive history data were 
entered into the medical birth registry. The mothers’ records are linked to their children’s 
records using a unique maternal hospital number assigned for each woman who deliver at 
KCMC for the first time. A total of 46,030 deliveries were recorded.  To analyse the effect of 
prepregnancy BMI on the risk of preeclampsia we included women who delivered singleton 
birth at first or second pregnancies while excluding other gravidities. To analyse the effect 
change in prepregnancy BMI/body weight between pregnancies on the risk of preeclampsia in 
the second pregnancy we included a woman’s first two singleton deliveries, irrespective of 
gravidity.  
Data collection 
Data collectors from this study were midwives from the obstetric unit who were trained for 
two days.  Along with this, one secretary was trained as data entry before the commencement 
of this project. The medical birth registry information is collected from all mothers who 
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deliver at KCMC. Midwives conduct the interview using a standardized questionnaire for all 
mothers within 24 hours after delivery, or later in case a mother had complications. The 
interviews were done on a daily basis including public holidays and weekends. Abstracted 
data from files relating to each mother written by obstetricians were also included. In 
addition, mothers admitted to the hospital were asked to provide their antenatal (ANC) cards 
for more clarification regarding their pregnancy records including pre pregnancy weight and 
height. Verbal informed consent was obtained from each mother prior to the interview, and a 
unique maternal hospital identification number was used to protect confidentiality. The details 
of data collected during interview are shown in questionnaire (Appendix 1). In summary, the 
information collected during interview and through inspection of medical files includes 
parents’ social-demographic characteristics, reproductive history, pregnancy and birth 
characteristics such as; maternal health before pregnancy, maternal health during pregnancy, 
and complications during labour and delivery, and new born health status. This information 
was then entered into a computerized data base system. The quality checks and validation of 
the birth registry information was done in 2004/2005 and the manual with definitions and 
detailed explanation was written and accessed in 2005 [50].  
The analyses are based on two sets of data; a set of first and second pregnancies where each 
pregnancy was the unit of analysis (“birth record” analysis, and a set of maternally-linked 
pregnancies where each mother was represented with two pregnancies and where the mother 
was the unit of analysis (“record linkage analysis”). Birth record analysis includes objectives 
1 – 3, whereas record linkage analysis includes objective 4. An overview of the birth record 
and the record linkage analysis is presented in Table 1. 
Inclusion criteria 
In the birth record analysis we included mothers who had pre-pregnancy body weight and 
height recorded and who delivered their first or second singleton birth at KCMC at any time 
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between July 2000 and May 2013. In the record linkage analysis we included a woman’s first 
two singleton births at KCMC, irrespective of gravidity. 
Exclusion criteria 
For objectives 1-3 we excluded women with multiple gestations, women who were referred 
from the rural area for various medical reasons, and those with missing information on the 
BMI variables. Our final sample consisted of 17,750 singleton births for the birth record 
analysis (Figure 2). For objective 4, in addition to the exclusion criteria of birth record 
analysis, we also excluded mothers whose information did not match between year of birth 
and mother’s age and women with preeclampsia in the first pregnancy. However, we included 
mothers who had only one valid measurement of maternal height. Our final sample consisted 
of 3,595 women in the record linkage analysis (Figure 3). 
Study variables 
Outcome variables: For all objectives our outcome was preeclampsia, defined as gestational 
hypertension of at least 140/90 mmHg measured on two separate occasions =≥4 hours apart 
accompanied by significant proteinuria of at least 300 mg in a 24-hour collection of urine, 
arising after the 20th week of gestation in a previously normotensive woman. This definition 
of preeclampsia is in accordance with World health organisation, and includes mild, moderate 
and severe preeclampsia. For simplicity we use the term preeclampsia. In the analysis of 
change in prepregnancy BMI/body weight between pregnancies our outcome was incidence 
(%) of preeclampsia in the second pregnancy. 
Explanatory variable: In the birth record analysis (objectives 1 – 3) our main exposure 
variable was pre-pregnancy BMI based on self-reported maternal prepregnancy weight in 
kilograms and documented height in centimetres from ANC visits. Lower and upper cut-off 
points for height were set at 130 cm and 200 cm, respectively. Lower and upper cut-off points 
for body weight were set at 35 kg and 120 kg, respectively. BMI was calculated as body 
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weight in kg/height in metres squared, and we accepted BMI values between 15 and 40. We 
excluded records with BMI above 40 (0.4%) and BMI below 15 (0.5%). We categorized BMI 
according to WHO definitions as underweight ≤18.5, normal weight 18.5-24.9, overweight 
25.0-29.9 and obese ≥30.  
In the birth record analysis we included sociodemographic variables  (mother’s age, mother’s 
education, antenatal care visits, marital status, mother’s occupation, mother’s tribe, and 
mother’s height, ) categorised as in Table 2a. To assess whether effects of BMI were similar 
across maternal height categories (below 164 cm and 165 cm or more) and across gestational 
age categories (below 37 completed weeks and 37 completed weeks or more, and missing) the 
results were stratified. We also performed tests for interaction by adding an interaction term 
between BMI and maternal height or gestational age, in the model.  
In the record linkage analysis (objective 4) our exposure variables were change in pre-
pregnancy BMI or change in body weight between the woman’s first and the second 
pregnancy. Normal BMI was used as a reference group. Change in pre-pregnancy body 
weight was calculated by subtracting the body weight recorded in the second pregnancy from 
that in the first pregnancy (weight2-weight1) and categorised á priori into gained ≥ 10 kg, 
gained 5-9.9 kg, less than 5 kg change, lost 5-9.9 kg and lost ≥10 kg. Normal weight in both 
pregnancies was used as a reference. We tested for interaction between BMI in second 
pregnancy (linear), and BMI change. 
In all analyses, variables were entered into the multivariable model if they were associated 
with preeclampsia with a p-value less than 0.1 in the univariate analysis. In general, records 
with missing values were included only in the descriptive analysis of the participant 
characteristics. Since for each variable in the multivariable model the proportion of missing 
values was less than 1%, individuals with missing values on any independent variable were 
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not included in the model. In the analysis where we stratified for gestational age, missing 
gestational age (8.1%) was analysed as a separate category. 
Data analysis 
Data were extracted from Microsoft Access data base and then transferred to Statistical 
Package for Social Science (SPSS) version 20 for Windows for analysis, then followed by 
data cleaning. Descriptive analysis including means and proportion were calculated. To assess 
the statistical associations Pearson Chi-squres statistics test were used to compare categorical 
variables across BMI categories. The significance level was set at p=0.05, with 95% as the 
preferred confidence interval. P for trend was calculated and reported for ordinal variables. 
Binary and multivariable logistic regression analysis was performed to assess the strength of 
association between dependent and independent/explanatory variables while adjusting for 
potential confounders; mother’s age, mother’s education, mother’s body height, pre 
pregnancy body mass index, and mother’s tribe. Adjusted odds ratios with 95% confidence 
intervals were reported. 
Ethical issues 
Ethical clearance 
The ethical approval was sought from Kilimanjaro Christian Medical University College 
research ethics committee prior the commencement of this study (Appendix 2). Also the birth 
registry at KCMC had ethical clearance from the Tanzania national institute for medical 
research (NIMR) 2003 (Appendix 3), and from the Regional Ethical Committee (Health 
Region III) in Norway 1999 (Appendix 4). To every enrolee, the research study, its goal and 
benefit was clearly explained and this was followed by orally consent. Participation was on 
voluntary basis and mothers were taught to be free to disagree to be interviewed if they 
wished to do so. There was no penalty if they decided not to be interviewed, and their 
decision would not affect the provision of appropriate care and management. Confidentiality 
25 
 
was guaranteed during the interview process. The completed questionnaires were kept in a 























5.0 Discussion on methods  
Discussion of this thesis includes literature on definition, classification, risk factors, aetiology, 
complications and management of preeclampsia. Further literature on obesity and BMI, most 
articles published from 2000 to 2013. Key terms were preeclampsia, eclampsia, obesity, BMI, 
pregnancy, developing countries, Tanzania and Kilimanjaro. The literatures were retrieved 
from Google Scholar, Cochrane Database of Systematic Reviews and PubMed (MEDLINE).  
Design 
This study was a historic cohort study, and the design should be appropriate for the study 
question, because we set out to examine the association of prepregnancy BMI and changes of 
pre-pregnancy BMI/body weight on risk of preeclampsia. Our study is based on existing 
registry data and we did not perform any sample size computations. We consider the 
following as methodological challenges in this study. 
5.1 Methodological Challenges 
Internal validity 
Internal validity refers to the degree to which the data measure what is intended to measure 
[51]. Bias refers to the lack of internal validity [52]. Bias is a systematic error which can be 
encountered in sample selection and data collection [51]. 
Internal validity depends on the presence of information bias, selection bias, or confounding. 
Information Bias 
 Information bias is a distortion in the measure of association caused by inaccurate 
information. It is mostly occur during data collection [52]. The most common type of 
information bias is misclassification bias which refers to specificity and sensitivity of the 
test/procedure used to identify the exposure and effect/outcome. Differential misclassification 
occurs when the misclassification is different between the groups which are compared, for 
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example that misclassification in exposure differs between those who have the outcome and 
those who not have the outcome. We have non differential misclassification if 
misclassification is similar across the groups which are compared. Although using a 
standardized questionnare during interview is the most effective method in gathering high 
quality information, in our study there is a possibility for less accuracy of the respondents to 
recall events such as body weight before pregnancy, last normal menstrual period etc. To 
minimize error in the collection of information, data collectors were trained, the standardized 
questionnaire was piloted before the data collection started, and in year 2005 the registry 
produced an instruction manual which further improved quality of data [50]  
Selection Bias 
Selection bias is a systematic error resulting from sample selection [51].  Since KCMC is a 
referral hospital receiving complicated pregnancies, there is a likelihood of overestimating 
measures of diseases. Approximately 86.7% of women give birth at health facility in 
Kilimanjaro region.  To minimize selection bias, we excluded women who were referred from 
the rural area for medical reasons such as complications in current or previous pregnancies. 
 
Loss to follow up has been reported to be important in follow up studies. To our 
understanding, we agree there is a challenge of identifying subsequent deliveries of the same 
women. KCMC being a referral hospital in which women can be referred for one pregnancy 
and the second birth delivered to her nearby health facility she lives. Therefore to link 
reproductive health/ outcome and mother’s birth we used a unique identification number,   
while excluding women who were having mismatched information between year of birth and 
maternal age, however women who were lost in subsequent birth might have different 





Observational studies may be affected by confounders [52]. A confounder is a third factor 
which correlates with both dependent and independent variables. Confounding can be 
controlled/ minimized during study plan by matching or restriction, and during analysis by 
stratification, matched analysis or multivariable analysis. In both analyses we restricted our 
sample to singleton birth by excluding multiple pregnancies. In addition we performed 
multivariable adjustment to control of confounders. 
 
External validity 
External validity refers to which degree the results obtained from one population can be 
projected to the rest of that population/other settings. Moreover external validity goes together 
with internal validity though the presence of internal validity does not guarantee the external 
validity [51]. The distribution of characteristics of women who delivered in this setting might 
be different from those who delivered outside KCMC. For example, home deliveries in the 
Kilimanjaro region are approximated to be 12% [46]. 
Therefore, generalization of the results needs to be taken with precaution. 
 
Recommendations and policy implications 
The association of prepregnancy obesity with risk of preeclampsia in this population 
corresponds with earlier findings from developed countries.  Midwife should counsel 
pregnant women on the consequences associated with high prepregnancy weight. Health 
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Preeclampsia is among the three leading causes of maternal mortality and morbidity 
worldwide, occurs in 6-8% of all pregnancies, and is estimated to account for at least nine 
percent of maternal deaths in Africa. Studies from developed countries show that high 
prepregnancy BMI increases the risk of preeclampsia. We examined 1. The effect of 
prepregnancy BMI and 2. Changes of prepregnancy BMI/body weight between pregnancies, 
on the risk of preeclampsia in the second pregnancy. In the term preeclampsia we also include 
cases of eclampsia. 
Method 
A historic hospital registry study design was used, analysing births registered in the 
Kilimanjaro Christian Medical Center (KCMC) birth registry between July 2000 and May 
2013. Two sets of data were analysed; singleton births of gravida 1 or 2 mothers (n= 17, 750 
births), and the linked first two recorded singleton births to a woman, irrespective of gravidity 
(n =3, 595 mothers). Prepregnancy BMI was categorized according to WHO categories 
underweight (less than 18.5), normal (18.5 – 24.9), overweight (25.0 – 29.9) and obese (30 or 
more). Measured confounders were adjusted for in the multivariable model. 
Results 
Among the 17,750 singleton births, 9.1 % of the mothers were underweight, 24.0 % were 
overweight, and 7.4 % were obese. Five hundred and eighty-two pregnancies (3.3 %) were 
affected by preeclampsia. Compared to women of normal BMI, overweight and obesity was 
associated with risk of preeclampsia (AOR 1.5 (95%CI 1.2 – 1.7 and, 1.7(1.2 – 2.1), 
respectively, while underweight was protective (AOR 0.8 (0.8 - 1.1). Among the 3,595 
mothers with linked pregnancies, incidence of preeclampsia was 2% in the second recorded 
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pregnancy. Weight loss, but not weight gain between pregnancies was associated with an 
increased risk of preeclampsia in the second pregnancy. The effect of weight change between 
pregnancies was not related to BMI per se.  
Conclusion 
Pre pregnancy maternal overweight or obesity increased the risk of preeclampsia. Both weight 
loss and weight gain from one pregnancy to a next pregnancy increased the risk of 
preeclampsia, although not statistically significant for weight gain. Overweight and obesity 
among pregnant women should be considered as a challenge also in developing countries.  
Keywords:  Preeclampsia, eclampsia, obesity, BMI, pregnancy, developing countries, birth 
registry, Kilimanjaro and Tanzania. 
Introduction 
Globally it has been estimated more than 287,000 women die each year due to pregnancy 
related causes [1]. Complications of pregnancy and childbirth are the leading cause of death 
amongst women of reproductive age. The majority of maternal deaths occur in developing 
countries including Tanzania [2]. Worldwide, 10-15% of direct causes of maternal death are 
estimated to be due to preeclampsia [3]. The focus of millennium development goal number 
five is to reduce maternal mortality by three quarters by 2015. This has been a challenge for 
developing countries in which maternal mortality is 100-200 higher than in developed 
countries [3]. Ten percent of all pregnancies are affected by hypertension, of which 2 to 8% 
are complicated by preeclampsia [3, 4]. Preeclampsia has been reported to increase the risk of 
maternal mortality by 1.8% in developed countries and by 14% in developing countries  
 
 Preeclampsia is a multi-system disease, and is characterized by  systolic blood pressure of 
>=140mm Hg and diastolic blood pressure of   >= 90 on at least two occasions in four hours 
35 
 
apart after 20 weeks of gestation in a previously normotensive woman, combined with 
proteinuria [5-7]. The etiology of preeclampsia is still unknown although the following 
factors have been reported to play a role: the placenta, genes, the immune response, and 
maternal vascular disease [3]. Duley et al further explained that endothelial dysfunction from 
poor blood supply to the placenta accounts for the secondary changes in maternal target 
systems such as vasoconstriction which is responsible for the signs and symptoms of 
preeclampsia. There is no efficient treatment of preeclampsia rather than symptomatic 
management since the cause is unclear [4]. Preeclampsia is associated with several 
complications which include eclampsia, ischemic or hemorrhagic stroke, abruptio placentae, 
hemolysis, liver damage, and thrombocytopenia (HELLP syndrome with or without 
hemorrhage), disseminated intravascular coagulation, liver hemorrhage/rupture, pulmonary 
edema, adult respiratory distress syndrome, acute renal failure and death [8]. Eclampsia is the 
presence of convulsions in any woman who has preeclampsia, or then presents with, 
hypertension in pregnancy of any cause [9]. 
  
Risk factors for preeclampsia have been well documented [10-12]. These include nulliparity, 
advanced maternal age, race other than white, high body mass index (BMI), chronic 
hypertension, diabetes (I/II), previous preeclampsia, previous intrauterine growth restriction 
(IUGR), previous abruptio placenta, long time since previous pregnancy, multiple pregnancies 
and previous stillbirth. The risk of preeclampsia is associated with a raised pre-pregnancy 
BMI [12]. The association between risk of pre-eclampsia and increase in BMI between two 
pregnancies have been reported [13]. Moreover, both obesity and overweight during 





Obesity is a serious global public health problem and has consequences for nearly all areas of 
medicine. Obesity has been reported to increase the risk of preeclampsia about 3 fold and is 
the leading identified attributable risk for this disorder. In obstetrics, obesity not only has a 
direct implication for the health of a pregnant woman but also has impact on the offspring’s 
weight during infancy and beyond. As such, maternal weight may influence the prevalence 
and severity of obesity in future generations. In many populations the prevalence of obesity 
among pregnant women has been reported to increase significantly over the decade, and this 
has negative effect on many aspects of female reproductive life included preeclampsia [13]. 
Pregnancy has been identified as a key period to target a weight control or weight loss 
strategy to help curb the rapidly growing obesity epidemic [14].  
 
A study among US women by Getahun and his colleagues [10] revealed that the risk of 
preeclampsia increased with increasing BMI between pregnancies. BMI is widely accepted as 
a measure of both overweight and underweight [15]. Overweight and obesity in pregnancy 
have been associated with an increased risk of different maternal complications including pre-
eclampsia whereas babies born to these women are at increased risk of neonatal complications 
[16]. On the other hand, underweight increases the risk of preterm delivery, low birth weight 
and anaemia, but lowers the risk of pre-eclampsia, gestational diabetes, obstetric intervention 
and post-partum hemorrhage [14]. 
Few studies from low and middle income countries have reported on obesity and pregnancy. 
In a study of women of reproductive age in South Asia [17] revealed that there is an increase 
of overweight and obesity among women of this age group. Also the rate of obesity among 
women of reproductive age in Tanzania has been increasing significantly [18]. A 
Demographic Health Survey from the years 2004 and 2005 conducted in Tanzania found that 
the prevalence of overweight and obese among women of reproductive age was 18% and 4%, 
37 
 
respectively [18]. A population based study from Dar Es Salaam, Tanzania, shows that the 
prevalence of obesity among women of reproductive age has increased progressively from 
3.6% to 9.1% between 1995 and 2004  [19]. We were not able to identify more recent studies 
on prevalence of overweight and obesity in women of reproductive age in Tanzania. Most of 
the studies regarding the effect of maternal pre-pregnancy BMI and changes of pre-pregnancy 
BMI on risk of pre-eclampsia in subsequent pregnancies have been done in high income 
countries. There is scarce information on this important topic in low income countries. We 
aimed to examine 1) The effect of prepregnancy BMI and 2) Changes of prepregnancy 
BMI/body weight between pregnancies on the risk of preeclampsia in the second pregnancy. 
Materials and methods 
This study was conducted at Kilimanjaro Christian Medical Center (KCMC), which is a 
private hospital based in Moshi urban district, Kilimanjaro region in Northern Tanzania 
(Figure 1). According to census 2012 the region has a population of 1,640,087 [20]. The two 
main ethnic groups in Kilimanjaro are Indigenous Chagga which is the third largest ethnic 
group in Tanzania and followed by Pare. There are also other small ethnic groups which have 
migrated to nearby Kilimanjaro such as the Kahe and Masai tribe. KCMC is one of the four 
zone referral hospitals in Tanzania. The hospital has different departments including an 
obstetric department which receives women from the local communities as well as referred 
women from other regions. The hospital has 450 beds, and as a tertiary care hospital it serves 
a population of more than 11 million. The medical birth registry at KCMC was established in 
collaboration with researchers at the Department of Global Public Health and Primary Care 
(formerly Department of Public Health and Primary Health Care) at the University of Bergen 
Norway, and has been in operation since July 2000.  
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This is a hospital registry study. Our source population included mothers who delivered at 
Kilimanjaro Christian Medical Centre (KCMC) from July 2000 to May 2013 and whose 
reproductive history data were entered into the medical birth registry. The mother’s records 
are linked to their children’s records using a unique maternal hospital number assigned for 
each woman who deliver at KCMC for the first time. A total of 46,030 deliveries were 
recorded.   
 
The data were prospectively collected by obstetricians and midwives from all women who 
delivered at Kilimanjaro Christian Medical Centre from July 2000 to May 2013. The medical 
birth registry information is collected from all mothers who deliver at KCMC. Trained nurse 
midwives conduct the interview using a standardized questionnaire for all mothers within 24 
hours after delivery, or later in case a mother had complications. The interviews were done on 
a daily basis including public holidays and weekends. Abstracted data from files relating to 
each mother written by obstetricians were also included. In addition, mothers admitted to the 
hospital were asked to provide their antenatal (ANC) cards for more clarification regarding 
their pregnancy records including pre pregnancy weight and height. Verbal informed consent 
was obtained from each mother prior to the interview, and a unique maternal hospital 
identification number was used to protect confidentiality. The details of data collected during 
interview are shown in questionnaire (Appendix 1). In summary, the information collected 
during interview and through inspection of medical files includes parents’ social-demographic 
characteristics, reproductive history, pregnancy and birth characteristics such as; maternal 
health before pregnancy, maternal health during pregnancy, and complications during labour 
and delivery, and new born health status.  Data were extracted from a Microsoft Access data 
base and then transferred to Statistical Package for Social Science (SPSS) version 20 for 
Windows for analysis. 
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The analyses are based on two sets of data; a set of first and second pregnancies where each 
pregnancy was the unit of analysis (“birth record analysis”, and a set of maternally-linked 
pregnancies where each mother was represented with two pregnancies and where the mother 
was the unit of analysis (“ record linkage analysis”). Birth record analysis includes objectives 
1 – 3, whereas record linkage analysis includes objective 4. An overview of the birth record 
and the record linkage analysis is presented in Table 1. 
 
For objectives 1-3 we studied women who delivered their first or second singleton birth at 
KCMC between July 2000 and May 2013. We excluded multiple births, women who were 
referred from the rural area for medical reasons, and those with missing information on the 
BMI variables. Our final analysis sample consisted of 17,750 singleton births (Figure 2).  
For objective 4 we included a woman’s first two singleton deliveries at KCMC between July 
2000 and May 2013, irrespective of gravidity. In addition to the exclusion criteria as 
presented in Figure 2, we excluded mothers with preeclampsia in first recorded pregnancy and 
mothers whose information on year of childbirth and mother’s age for the two pregnancies did 
not match. We included mothers who had at least one valid measurement of maternal height. 
The final sample consisted of 3595 mothers (Figure 3). 
 
For all objectives our outcome was preeclampsia, defined as gestational hypertension of at 
least 140/90 mmHg measured on two separate occasions =≥4 hours apart accompanied by 
significant proteinuria of at least 300 mg in a 24-hour collection of urine, arising after the 20th 
week of gestation in a previously normotensive woman. This definition of preeclampsia is in 
accordance with WHO, and includes mild, moderate and severe preeclampsia.  
The main exposure variable for objectives 1-3 (birth record analysis) was pre-pregnancy BMI 
based on self-reported maternal prepregnancy weight in kilograms and maternal height in 
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centimetres from ANC visits. Lower and upper cut-off points for height were set at 130 cm 
and 200 cm, respectively. Lower and upper cut-off points for body weight were set at 35 kg 
and 120 kg, respectively. BMI was calculated as body weight in kg/height in metres squared, 
and we accepted BMI values between 15 and 40. We excluded records with BMI above 40 
(0.4%) and BMI below 15 (0.5%). We categorized BMI according to WHO definitions as 
underweight ≤18.5, normal weight 18.5-24.9, overweight 25.0-29.9 and obese ≥30.  
 
The main exposure variables for objective 4 (record linkage analysis) were change in pre-
pregnancy BMI/body weight between the first and second recorded pregnancy. The BMI was 
categorised as described above. Change in prepregnancy body weight was calculated by 
subtracting the body weights measured at first ANC visits in connection with the two 
pregnancies (weight2-weight1). Normal weight in both pregnancies was used as a reference. 
We modelled weight change both in categories (gained 20-29.9 kg, gained 10-19.9 kg, gained 
5-9.9 kg, less than 5 kg change, lost 5-9.9 kg, lost 10-19.9 kg, lost 20-29.9 kg) and as a 
continuous variable in kg. We defined categories á priori. 
 
Descriptive statistics including means and proportions were calculated. Pearson Chi-square 
statistics was used to assess associations between BMI categories and categorical factors, and 
between preeclampsia and categorical factors. The significance level was set at p = 0.05. P for 
trend was computed for the ordinal variables like mother’s BMI, mother’s age, mother’s 
education and mother’s height. Binary and multivariable logistic regression analysis was 
performed to assess the strength of association between the dependent variable and 
independent variables. Unadjusted and adjusted odds ratios with 95% confidence intervals 




For birth record analysis we included sociodemographic variables (mother’s age, mother’s 
education, antenatal care visits, marital status, mother’s occupation, mother’s tribe, and 
mother’s height) as presented in Table 2a in the multivariable model. In a second step we 
included some potentially mediating factors in the multivariable model; chronic hypertension, 
diabetes mellitus, and heart diseases before pregnancy, to explore if the association between 
BMI and preeclampsia was explained by these factors. To assess whether effects of BMI were 
similar across maternal height categories (below 164 cm and 165 cm or more) and across 
gestational age categories (below 37 completed weeks and 37 completed weeks or more), we 
performed analyses stratified for maternal height and gestational age. We also tested for 
interaction by adding an interaction term between BMI and maternal height/gestational age in 
the model. For record linkage analysis we tested for interaction between BMI in a second 
pregnancy as a linear term and BMI change. 
For objective 4, sociodemographic characteristics in second pregnancy (maternal age, 
education, prenatal care, marital status, and body mass index) were included in the 
multivariable model Table 4. Prepregnancy BMI in second pregnancy and effect on 
preeclampsia was analysed in a multivariate model in three steps Table7 
 
In all analyses, variables were entered into the multivariable model if they were associated 
with preeclampsia with a p-value less than 0.1 in the univariate analysis. Records with 
missing values were included only in the descriptive analysis of the participant characteristics. 
Since for each variable in the multivariable model the proportion of missing values was less 
than 1%, individuals with missing values on any independent variable were not included in 
the model. In the analysis where we stratified for gestational age, missing gestational age 




The ethical approval was sought from Kilimanjaro Christian Medical University College 
research ethics committee prior the commencement of this study (Appendix 2). Also the birth 
registry at KCMC had ethical clearance from the Tanzania national institute for medical 
research (NIMR) 2003 (Appendix 3) and from the Regional National Ethics committee 
(Health Region III) Norway 1999. (Appendix 4) 
Results 
Objectives 1 – 3 (birth record analysis)  
In the analysis of 17, 750 first and second singleton births, overall prepregnancy mean BMI 
was 23.5, 9.1 % were underweight, 24.0 % were overweight and 7.4 % were obese (Table 
2a). The highest mean BMI was found among mothers above 35 years of age, women who 
had the highest education, women with four or more ANC visits, married women, business 
women, professional women, Pare tribe and women who had body height between 155cm -
164cm. The highest proportion of underweight mothers was found among teenage mothers, 
mothers without education, mothers who were missing information on ANC visits, single 
mothers, mothers who were students during pregnancy, mothers who had body height above 
165cm and women from other tribes apart from Chagga and Pare. The highest proportion of 
overweight and obese mothers was among mothers above 30 years of age, women with the 
highest education, mothers who attended four or more ANC visits, women who were married, 
business women, and women who had professional work.  
 
Women having their second child and women with chronic hypertension and gestational 
hypertension or diabetes before pregnancy had a higher mean BMI and a higher proportion of 
overweight and obesity than women having their first child and women without chronic 
hypertension and gestational hypertension or diabetes (Table 2b).  Being underweight was 
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most common among women with heart diseases before pregnancy (22.6 %), while obesity 
was most common among women with chronic hypertension (18.4 %) and diabetes before 
pregnancy (19.0 %).   
   
Preeclampsia was recorded in five hundred and eighty-two pregnancies (3.3 %) (Table 3).  
The risk of preeclampsia increased with increasing mothers BMI, maternal age, maternal 
educational level, and body height (p-values for trend <0.05). Women with chronic 
hypertension, gestational hypertension or gestational diabetes, and women from the Pare tribe 
had a higher risk of preeclampsia than their counterparts. The risk of preeclampsia was 3.5% 
in first pregnancy and 3.0% in second pregnancy (data not presented on table).  
In the adjusted analyses (Table 3), overweight and obese women were 1.5 and 1.7 times more 
likely to have preeclampsia than women with normal BMI (95 % CI 1.2-1.7 and 1.2–2.1, 
respectively), while underweight women were less likely to have preeclampsia (OR 0.8, 95% 
CI 0.6-1.1). Mother’s age, height, tribe and marital status were still associated with pre-
eclampsia after adjustment, and the trend was significant for prepregnancy BMI and mother’s 
age. We further adjusted for potential mediators such as chronic hypertension, heart diseases 
and diabetes before pregnancy. The effect of BMI only slightly changed, with odds ratios for 
underweight, overweight and obese women 0.8, 1.4, and 1.6, respectively (data not presented 
in table).  
 
We further stratified our data into gestational age less than 37 weeks (preterm) and 37 and 
more weeks (term) and tested for interaction between gestational age and BMI using BMI as a 
linear term (results not presented in a table). For completeness, also results for missing 
gestational age were included. The association between BMI and preeclampsia was stronger 
in term births than in preterm births (adjusted odds ratio 2.0 and 1.1, respectively, for obese 
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vs. normal), and p-value for trend was only significant in term births (0.188 in preterm births 
vs. ≤0.001 in term births). However, p-value for interaction was non-significant (0.18). We 
also tested for a possible interaction between mother’s height and BMI using prepregnancy 
BMI as a linear term (results not shown in a table). The effect of BMI was stronger in woman 
below 165 cm than in woman above 165cm (adjusted OR 1.8 vs. 1.4) in the obese group. 
However the differences did not reach statistical significance, p value for interaction 0.53. 
Objective 4 (record linkage analysis) 
Table 4 describes sociodemographic characteristics in the second recorded pregnancy in 
relation to preeclampsia for the 3,595 women who were recorded with (at least) two singleton 
births. Only prepregnancy BMI was statistically associated with risk of preeclampsia.  
The rate of preeclampsia in the second recorded pregnancy was 2% (Table 5). Mothers with 
normal BMI in both pregnancies were the largest category and formed the reference group. 
Women who had normal BMI in first pregnancy did not increase their risk of preeclampsia in 
second pregnancy if their BMI category changed to overweight or obese. Women who were 
overweight in both pregnancies did not have an increased risk of preeclampsia in second 
pregnancy, whereas women who were overweight in first pregnancy and obese in second 
pregnancy had an increased risk in second pregnancy (AOR 2.2). Interestingly, women who 
had normal BMI in first pregnancy and were underweight in second pregnancy had a high risk 
of preeclampsia; adjusted odds ratio 6.0 (1.7-21.5) although this is based on small numbers 
(37 women). 
In a corresponding analysis of weight change between pregnancies (Table 6) we found high 
risk of preeclampsia both among women who lost weight (10 or more kg) and among women 
who gained weight (20 or more kg). P-value for trend was only significant among women 
who lost weight. We further analysed weight gained/lost as a continuous variable (in 
kilograms) in the multivariate model, where we found no statistically significant associations 
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(adjusted P value 0.797 for weight gain and 0.074 for weight loss) (results not presented in 
table). 
 
Prepregnancy BMI in second pregnancy and effect on preeclampsia was analysed in a 
multivariate model in three steps (Table 7); first step in bivariate analysis, second step with 
covariates, and the third step with covariates and the weight change as categorical variable. In 
all three steps, obesity was associated with risk of preeclampsia (OR 2.3, 2.0, and 2.0 
respectively, although not statistically significant in the last step). We also tested for 
interaction between BMI in second recorded pregnancy as a linear term with BMI change, 
where we found it is non-significant (P for interaction 0.421) 
Discussion  
Objectives 1 – 3 (birth record analysis) 
Results from our study add to the increasing body of evidence which suggests that 
prepregnancy weight gain predispose women to preeclampsia. We found a positive 
association between higher body mass index and the risk of developing preeclampsia, 
gestational hypertension and chronic hypertension. Conversely, low BMI had a protective 
effect on preeclampsia.  
 
Previous research has found a strong association between increasing BMI and preeclampsia 
[21]. Other studies have reported that the risk of preeclampsia increases rapidly from BMI 
values of 15-30 [22], we have found the same results. The prevalence of underweight, 
overweight and obese was found to be 9.1%, 24% and 7.4% respectively. A study on primary 
preeclampsia in the second pregnancy conducted by Getahun D et al [10] found a prevalence 
of 7.8%, 19.5% and 13.2% respectively. We found a 1.5 times higher risk of pre-eclampsia in 
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overweight (BMI 25.0-29.9 Kg/m2) and a 1.7 times higher risk in obese (BMI > 30 Kg/m2) to 
women who delivered singleton birth. Similarly Sohinee et al [23] found the risk of 1.7 and 
3.1 among nulliparous women delivering singleton babies in Aberdeen. We also found a 
significantly lower risk of pre-eclampsia in underweight women (OR 0.8(95% CI 0.6 – 1.1)), 
a finding collaborated by Sohinee Bhattacharya et al [15] 
 
Women of advanced maternal age were reported to have a higher occurrence of preeclampsia 
compared with the younger ones 6.5% vs. 2.8% and they were more likely to have an 
increased body mass index of ≥24kg/m2. Sohinee et al [24] reported similar findings that the 
risk of preeclampsia increased with increasing BMI. Older women were 2.3 times more likely 
to have preeclampsia compared to women under 35 years of age. The study of registry-based 
on primiparous women in Finland 1997-2008 reported similar increased risk [25]. Another 
study conducted among Brazilian population [2] concluded that women who were older with 
high BMI during pregnancy had a risk of hypertension disorders including preeclampsia 
compared to their counterpart. 
 
Other researchers have reported gestational hypertension to be linked with an increasing 
maternal weight and risk of developing preeclampsia [26]. This association was also observed 
in this study. 
We also reported preterm associated with increased risk of preeclampsia, whereas term birth 
was seen to have higher risk of preeclampsia compared to preterm birth. Women who were 
underweight had increased risk of preterm birth compared to women who were term (data not 
presented in the table). The findings collaborated by Ali Khatib et al [27]. Compared to 
women of normal BMI, obese women were more likely to have university education. This is 
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contrast with a study done by Chaturica et al [26] who reported obese women were less likely 
to obtain university knowledge than health weight women. 
Objective 4 (record linkage analysis) 
The risk of developing preeclampsia in the second pregnancy had a relationship with the 
prepregnancy BMI in the first pregnancy [10]. Getahun et al reported similar findings from 
his study which shows risk of preeclampsia in the second pregnancy depends not only on 
BMI in the present pregnancy, but also BMI in the previous pregnancy. Additionally his study 
showed the increased risk of preeclampsia when woman is overweight or obese in both 
pregnancies. We have observed the same findings. We also showed the association of 
decreased prepregnancy BMI and increased risk of preeclampsia, for example in those women 
who went from normal to underweight. This is contrast with the study done by Getahun et al 
[10] who revealed the decreased prepregnancy BMI reduced the risk of preeclampsia. 
Similarly women who gained 20kg or more between pregnancies were at increased risk of 
preeclampsia. The corresponding findings by I-Hsien Tsai MS et al, a gestational weight gain 
of >18kg increases the risk of preeclampsia [28]. 
 
 The mechanism that higher body weight before pregnancy is associated with risk of 
preeclampsia is not clear. However adipose tissues from overweight and obese women 
thought to secrets inflammatory substances which can lead to chronic inflammatory and hence 
affects vascular activities. The etiology of preeclampsia remains unclear, though it has been 
reported to be a disease of endothelia dysfunction in which the cause of endothelial 
dysfunction is unknown [29]. The following factors have been mentioned to contribute to its 
mechanisms, obesity associated with inflammatory responses, immunological maladaptation, 




The strength of our current study was that it used data from the hospital-based cohort 
(hospital registry). Data stored in this registry have been reported to demonstrate both high 
validity and quality, confirming that hospital registries are a valuable resource in studying 
maternal and obstetric health outcomes, therefore identification of preeclampsia is shown to 
be accurate in such databases. Missing values for some variables and loss to follow up in the 
record linkage can affect our results. Most variables with missing values accounts for less 
than 1% and were not included in the multivariate analysis. Limited cases from sample size 
may lead to selection and misclassification bias, since we excluded all women who have 
preeclampsia in the first pregnancy and prepregnancy weight and height data used in this 
study were collected during ANC visit before the women develop preeclampsia, thus if small 
number of preeclampsia were misclassified so that bias would be differential 
misclassification. We also acknowledge the use of self-reported maternal prepregnancy 
weight as a limitation; it is possible that the calculated BMI may have been underestimated. 
However this have previously shown to be reliable for clinical researches. Unmeasured 
factors such as nutritional diet before and during pregnancy may lead to residual confounders 
and thus affect our study findings. The relatively small number of cases of preeclampsia led to 
wide confidence intervals for some BMI values.  To our knowledge, these findings cannot be 
generalizable to all hospitals in Tanzania, rather to the similar hospital as KCMC and KCMC 
itself. We did not study the effect of prepregnancy BMI in association with neonatal outcome 
which could have given us a more comprehensive picture. Future studies with larger samples 
of overweight and obese women should be carried out to more accurately assess the 






These findings add to the knowledge that prepregnancy BMI is associated with increased risk 
of preeclampsia. Overweight, obesity, weight loss between pregnancies, old age, and first 
pregnancy were associated with higher likelihood of preeclampsia. Similarly chronic 
hypertension and gestational hypertension were also associated with increased risk of 
preeclampsia. This calls for clinicians to counsel pregnant women on the consequences 
associated with high prepregnancy weight. 
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99 missing hospital number and year of birth.  
105 births before year 2000 
2, 493 multiple pregnancies 
170 with missing referral status 
3, 449 rural medical referral 
14,339 gravida 3+ 
25,382 gravida 1 and 2 
7,625 missing prepregnancy BMI were 
excluded 
17,750 gravida 1 and 2 with 
prepregnancy BMI 
17,168 without preeclampsia 
582 with preeclampsia 




Figure 3: Population flow diagram (analysis of women with at least two recorded 















































Cohort of births from May 2000 – July 
2013: N =46,030 
29,589 mothers with 1or more births 
4,734 mothers with 2 or more births   
N =3,595 mothers with 2+ births 
Excluded: 
99 missing hospital number and year of birth. 
105 births before year 2000 
2,493 multiple births 






24,780 mothers with only one birth 
were excluded 
Excluded: 
464 mismatch year of birth and mother’s age 
161 medical referrals 
159 missing height 
158 preeclampsia in 1
st
 pregnancy 
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Table 2a: Sociodemographic characteristics of the participants in relation to BMI (main 











BMI > 30 
Obese 
Pearson χ2  
p-value 
Overall (n) 17,750  1623 10563 4258 1306  
%  23.5 9.1% 59.5% 24% 7.4%  






















































Secondary (8-11 yrs) 






























































































































































































































Table 2b: Maternal health related characteristics in relation to BMI (main exposure) 











BMI > 30 
Obese 
Pearson χ2  
p-value 
Overall (n) 17750  1623 10563 4258 1306  
















































































































































































Table 3: Relationship between risk factors and preeclampsia among singleton deliveries 







χ2 Crude OR and  
95% CI 
P-value Adjusted OR 
and 95% CI 
P-value 
Mother's BMI      <0.001         
<18.5 underweight 1583 40 (2.5%)  0.9 (0.6-1.2) 0.4 0.8 (0.6-1.1) 0.206 
18.5-24.9 normal 10264 299(2.8%)  Ref Ref Ref Ref 
25.0-29.9 overweight 4077 181 (4.3%)  1.5 (1.3-1.8) <.001 1.5 (1.2-1.7) 0. 001 
30 thru highest obese 1244 62 (4.7%)  1.7 (1.3-2.3) <.001 1.7 (1.2-2.1) <0.001 
P for trend  < 0.001  <0.001  <0.001  
Mother's age   <0.001     
13-19 2090 61(2.8%)  1 (0.8 - 1.5) 0.59 1 (0.7-1.4) 0.996 
20-24 6270 169 (2.6%)  Ref Ref Ref Ref 
25-29 5570 187 (3.2%)  1.3 (1.0-1.5) 0.041 1.1 (0.9-1.4) 0.279 
30-34 2497 114 (4.4%)  1.7 (1.3-2.2) <.001 1.5 (1.1-1.9) 0.006 
35-50 708 49(6.5%)  2.6 (1.9-3.6) <.001 2.3 (1.6-3.2) <0.001 
P  for trend  < 0.001  <0.001  <0.001  
Mother's education   0.082     
None 172 5 (2.8%)  0.8(0.3-1.9) 0.55 1.2 (0.5-2.9) 0.744 
Primary 8847 277 (3.0%)  0.8 (0.7-1.0) 0.022 1.1 (0.9-1.4) 0.401 
Secondary (8-11) 1112 31 (2.7%)  0.7 (0.5-1.0) 0.101 0.8 (0.5-1.3) 0.338 
Higher (12+) 7012 268 (3.7%)  Ref Ref Ref Ref 
P  for trend  0.022  0.022  0.678  
Marital status   0.002     
With partner 14357 459 (3.1%)  0.7 (0.6-0.9) 0.003 0.7 (0.6-0.9) 0.003 
Without partner 2749 120 (4.2%)  Ref ref   
Mother's occupation   < 0.001     
Housewife 3464 104 (2.9%)  1 (0.8-1.4) 0.91 1 (0.7-1.4) 0.881 
Farmer 2706 80 (2.9%)  Ref Ref Ref Ref 
Service 1227 59 (4.6%)  1.6 (1.1-2.3) 0.005 1.4 (1.0-2.0) 0.054 
Business 4018 113 (2.7%)  0.9 (0.7-1.3) 0.736 0.8 (0.6-1.2) 0.306 
Professional 3630 161 (4.2%)  1.5 (1.1-2.0) 0.004 1.3 (0.9-1.8) 0.181 
Student 573 19 (3.2%)  1.1(0.7-1.9) 0.658 1.1 (0.6-1.9) 0.727 
Mother's tribe   <0.001     
Chagga 9884 290 (2.9%)  Ref Ref Ref Ref 
Pare 1952 93(4.5%)  1.6 (1.3-2.1) <0.001 1.9 (1.4-2.4) <0.001 
Others 5332 199 (3.6%)  1.3 (1.0-1.5) 0.01 1.4 (1.2-1.8) <0.001 
Mother's  height   0.005     
<155 cm 4022 125 (3.0%)  0.7 (0.6-0.9) 0.012 0.7 (0.6-1.0) 0.023 
155-164 cm 8668 270 (3.0%)  0.7 (0.6-0.9) 0.002 0.7 (0.6-0.9) 0.003 
≥165 4478 187 (4.0%)  Ref Ref Ref Ref 
P for trend  0.007  0.007  0.069  
*All variables are in the multivariable model.   
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Table 4: Sociodemographic characteristics in the second recorded pregnancy in relation 
to preeclampsia among 3595 women (objective 4, record linkage analysis). KCMC 









P value Adjusted 
OR* 
P value 
Overall 3595 72 (2.0%)      
        
Maternal age (y)   0.88     
Less than 25 707 15 (2.1)  1.1 0.72 1.3 0.5 
25-34 2150 41 (1.9)  ref  ref  
35 or more 738 16 (2.2)  1.1 0.66 1.0 0.9 
P for trend  0.94      
        
Maternal 
education 
  0. 24     
Less than 12 1912 32 (1.7 %)  0. 7 0. 1 0. 7 0. 18 
12 183 3 (1.6 %)  0. 7 0. 4 0. 7 0. 54 
13 1497 37 (2.5 %)  ref  ref  
P for trend  0. 10      
        
Marital status   0. 91     
Married 3474 70 (2.0 %)  ref  ref  
Unmarried 107 2 (1.9 %)  0. 9 0. 9 1.0 0. 95 
        
ANC visits   0. 24     
Less than 4 2257 39 (1.7 %)  ref  ref  
Equal or more 
than 4 
1311 30 (2.3 %)  1.3 0. 2 1.3 0. 32 
        
BMI   0. 024     
Less than 18.5 79 3 (3.8 %)  2.7 0. 11 2.7 0. 11 
18.5-24.9 1571 23 (1.5 %)  ref  ref  
25.0-29.9 1279 24 (1.9 %)  1.3 0. 39 1.2 0.54 
30 or more 666 22 (3.3 %)  2.3 0. 006 2.0 0.002 
P for trend  0. 03      






Table 5: Association between changes in BMI between pregnancies and risk of 
preeclampsia in the second recorded pregnancy among 3, 595 women (objective 4, 










Crude OR and 
(95%CI) 
 
P value Adjusted OR* 
and 95%CI 
P value 
Underweight Underweight 36 0     
Underweight Normal 90 0     
Underweight Overweight 19 0     
Underweight Obese 1 0     
Normal Underweight 37 3 (8.1 %) 5.8 (1.6 -20.4) 0.006 6.0 (1.7-21.5) 0.005 
Normal Normal 1334 20 (1.5 %) Ref  Ref  
Normal Overweight 629 13 (2.1 %) 1.4 (0.7-2.8) 0.363 1.2 (0.6-2.5) 0.58 
Normal Obese 120 2 (1.7 %) 1.1 (0.3 – 4.8) 0.89 1.1 (0.2-4.8) 0.90 
Overweight Underweight 4 0     
Overweight Normal 134 2 (1.5 %) 1.0 (0.2 – 4.3) 0.99 1.0 (0.2-4.5) 0.97 
Overweight Overweight 578 9 (1.6 %) 1.0 (0.5-2.3) 0.92 1.0 (0.5-2.3) 0.96 
Overweight Obese 298 12 (4.0 %) 2.8 (1.3-5.7) 0.006 2.2 (1.0-4.9) 0.046 
Obese Underweight 2 0     
Obese Normal 13 1 (7.7 %) 5.5 (0.7 – 44.1) 0.11 5.6 (0.7-45.9) 0.11 
Obese Overweight 53 2 (3.8 %) 2.6 (0.6-11.3) 0.21 2.8 (0.6-12.1) 0.18 
Obese Obese 247 8 (3.2 %) 2.2 (1.0 -5.0) 0.063 2.2 (0.9-5.0) 0.073 














Table 6: Weight change between pregnancies among 3595 women (objective 4, record 















and 95 % CI 
P value Adjusted OR 
and 95 % CI 
P value 
Lost weight        
-20 to -29kg 18 58.5 1 (5.6 %) 3.2 (0. 4-24.9) 0. 27 3.8 (0. 5-30) 0. 2 
-19 to -10kg  119 57.7 5 (4.2 %) 2.4 (0. 9-6.3) 0. 08 2.5 (0. 9 – 6.9) 0. 06 
-9 to -5kg 240 59.1 3 (1.2 %) 0. 7 (0. 2-2.3) 0. 54 0. 8 (0. 2-2.5) 0. 7 
P for trend    0.12  0.053  
 -4 to 4kg 1554 62.5 28 (1.8 %) ref  ref  
Gained weight        
 5 – 9kg 736 68.4 11 (1.5 %) 0. 8 (0. 4-1.7) 0. 59 0. 8 (0. 4-1.6) 0. 5 
10 – 19kg 740 74.5 17 (2.3 %) 1.3 (0. 6-2.4) 0. 42 0. 9 (0. 5-1.9) 0. 8 
 20 – 29kg 165 82.8 6 (3.6 %) 2.1 (0. 8-5.0) 0. 11 1.6 (0. 6-4.2) 0. 4 
P for trend    0.16  0.97  














Table 7: Prepregnancy BMI in second pregnancy and effect on preeclampsia among 
3,595 women (objective 4, record linkage analysis), Logistic regression in three steps. 
KCMC Medical birth registry July 2000 – May 2013. 
 *BMI BMI & 
**COVARIATES 
BMI, COVARIATES AND WEIGHT 
CHANGE 
BMI categories Preecla 
(N) 
OR 95% CI P value OR 95% CI P value OR 95% CI P value 
Underweight 3(3.8 %) 2.7 0.8 -9.0 0.11 2.7 0.8 – 9.1 0.1 2.2 0.6 – 7.8 0.2 
Normal 23(1.5 % ) ref ref  ref ref  ref ref  
Overweight 24(1.9 %) 1.3 0.7 – 2.3 0.39 1.2 0.7 – 2.2 0.5 1.2 0.6 – 2.3 0.5 
Obese 22 (3.3 %) 2.3 1.3 – 4.2 0.006 2.0 1.1 – 3.8 0.024 2.0 0.9 – 4.1 0.07 
*Main exposure: Prepregnancy BMI 























Appendix 1: questionnaire 
KCMC Medical Birth Registry  



















1.1 Mothers date of 
birth: 
 




Mothers name:    
1.4 Hospital number:     1.
3 
Address:    
1.6 Birth number:     1.
5 
Date of interview:    
1.8 Date of admission:     1.
7 
Interview by:    
 Referred for 
delivery: 
 1 Yes   If yes:   Referred from: Referred during 
labour:   2 No (self referral)  1 Home  1 Admitted in labour 
 Reason for referral:     2 Regional hospital  2 Admitted before 
labour        3 District hospital    
       4 Other, specify:    
 1.9 Official date of 
discharge: 
  1.10 Date leaving 
hospital: 
   
1.1
1 
Current residence:  1 Rural  1.12 Mothers childhood 
residence: 
 1 Rural 
   2 Urban    2 Urban 
   3 Semi urban     3 Semi urban 
 Area of mother's 
residence: 
     Area of mother's 
childhood residence: 
   









 1 Housewife 
   2 Primary (1-7)     2 Farmer 
   3 Secondary (8-
11) 
    3 Service 
   4 Higher (12+)     4 Business 





 1 Married Age at first 
marriage: 
  6 Student 
   2 Single     7 Others    
   3 Widowed      
   4 Remarried    No of previous 
pregnancies 
 
   5 Divorced     
   6 Polygamous 
family  
Add wife number:    
           If yes, at 
age:  





 1 Yes Age at 
menarch
e: 




 1 Yes  1 Type one 
  2 No    2 No  2 Type two 
           3 Type three  
1.1
8 
Mother’s tribe:  0
1 
Chagga  1.19 Religion:  1 Catholic  4 Other types 
   0
2 
Pare     2 Protestant 
   0
3 
Masai     3 Muslim 
    Other      4 Others   
2  Questions concerning the father of the child: 
2.1 Father’s name:    2.2 Father’s age:    
          
2.3 Current occupation of father:    2.4 Father’s  1 None 
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   0
1 
Farmer  06 Official  educational 
level: 
 2 Primary (1-7) 
   0
2 
Business  07 Professional   3 Secondary (8-11) 
   0
3 
Skilled worker  08 Student    4 Higher (12+) 
   0
4 
Unskilled worker  09 Unemployed 2.5 Father’s tribe:  1 Chagga 
   0
5 
Service  10 Other     2 Pare 
           3 Masai 
           4 Others   
             3  Questions concerning home conditions: 
3.1 Source of drinking 
water: 
 1 Tap water  3.3 Distance to water, if 
not tap: 
 1 Less than 1 km (less ½ hour 
walk)    2 Well    2 More than 1 km,  
specify in km:    3 River      
   4 Spring  3.4 Home toilet:  1 Pit latrine 
   5 Other, specify     2 Flush 
3.2 Boiling of drinking 
water: 
 1 Yes     3 Others  




4  Mothers health before and during present pregnancy 









 1 Yes 
      2 No 




Diabetes   0
6 
Anaemia   1
1 
Tuberculosis 
   0
2 







     0
3 







Other, specify  
    0
4 
Epilepsy   0
9 
Kid ey disease     
    0
5 




    
 4.5 Have you ever 
practised family 
planning: 
 1 Yes  Months trying to get pregnant: 
  2 No   




Pills   0
5 





Injections   0
6 





IUD   0
7 
Withdrawal   1
1 
Other specify  
   0
4 
Condoms   0
8 
Natural      
 4.6 Antenatal care in 
this pregnancy: 
 1 Yes If yes: First medical appointment 
date: 
   
  2 No         
         If date unknown, 
estimate first 
appointment : 
  1 0-12. week of gestation 
 Number of 
visits: 
         2 13-20. week 
         3 21-30. week 
            4 After 31. week  
 4.7 L.M.P:  4.
8 
Ultrasound   1 Yes  4.9 E.D.D. based on  






  1 Yes If yes: how many 
cigarettes per day: 
 Smoking during this 
pregnancy: 
 1 Yes 
    2 No   2 No 
               Chewing 
tobacco 
  1 Yes  Chewing tobacco during this 
pregnancy: 
 1 Yes 
    2 No  2 No 
              4.1
1 
Do you drink 
alcoholic 
beverages? 
 1 Yes  Did you also drink alcoholic 
beverages during this 
pregnancy? 
 1 Yes 
  2 No   2 No 
 If yes:  1 Every day    If yes:  1 Every day 
    2 More than once a week       2 More than once a week 
    3 Once a week       3 Once a week 
    4 Occasionally       4 Occasionally 
              4.1
2 
Drugs on regular 
basis? 
 1 Yes       Did  you take any drugs 
during this pregnancy: 
 1 Yes    
  2 No     2 No 
               If yes:  1 Modern    If yes, specify:   1 Modern 
    2 Traditional       2 Traditional 
               Did you take any 




 1 Yes       Drugs for infertility:  1 Yes 
  2 No       2 No 
          




Rh: Anti-D in 
previous 
pregnancies: 
 1 Yes VDRL 
status 
 1 Positive 
     2 No   2 Negative 
   Hb measurement do e:  3 Unknown   3 Unknown 
 Hb   1 On Admission        
    2 Last visit to ANC        
              Specify  HIV test 
recorded 
 1 Yes 
 
If yes, result:.    1 Negative Treatment during 
this pregnancy: 
 1 Yes 
     2 No   2 Positive  2 No 
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 1 Yes (specify below)  0
6 
Epilepsy   1
3 
Gynaecological  disease 
  2 No  0
7 
Bleeding      1
4 
Tromboembolic disease 
     0
8 
Anaemia   1
5 
Heart disease  
  0
1 
Gestational diabetes  0
9 
Hyperemesis   1
6 
Tuberculosis 




Malaria   1
7 
Lung disease  




Jaundice   1
8 
Infections, specify 
    2
0 
Preeclampsia, mild  
2 
Schistosomiasis   1
9 
Others, specify   
    2
1 
Preeclampsia, severe        
    0
5 
Eclampsia        
 
5 Questions concerning the delivery 
5.1 At birth  1 Single birth If multiple, add 
no. of  children: 






 1 PROM 
  2 Multiple birth   2 Bleeding > 500 ml  
      3 3-4. degree tear 
5.3 Induction of 
labour 
 1 Yes If yes:  1 Amniotomy 5.4 Others  1 Episiotomy  4 Abruption of placenta 
  2 No   2 Oxytocin    2 Symphysiotomy  5 Placenta previa 
     3 Prostaglandin       6 Other complications 
5.5 Analgesia:  1 Yes       Specify type other type of complication  
  2 No 5.8 Blood Loss (ml)  
    
5.6 Anaesthesia:  1 General         
  2 Spinal/Epidural 5.9 Mother’s health 
after delivery 
 1 Good  Cause of death:    
      2 Fair  Post mortem: 
5.7 Gestational age at birth 
clinical estimate 
   3 Bad   1 Yes 
    4 Maternal death   2 No 




Date of delivery 
 
 
 6.3 Sex  1 Male 6.4 Birth weight 
(gram)      2 Female  
6.2 Time of delivery    3 Unknown, unspec. 6.5 Length 
(cm) 
6.6 Head  
circum          
6.7 Presentation:  1 Cephalic 6.8 Status  1 Live born 
   2 Breech   2 Live born transferred to paediatrics dept 
   3 Transverse   3 Stillborn Cause of death 
   4 Other   4 Neonatal death  
 6.9 If stillborn:  1 Dead before labour  If stillborn, also specify: And: Post mortem: 
   2 Dead during labour   1 Dead before admission  1 Fresh  1 Yes   
   3 Unknown, unspec.   2 Dead after admission  2 Macerated  2 No   
 
6.10 Apgar 
score:   
1min 5 min 10 min 
If neonatal 
death: 
 1 Died within first 24 hours Date of death: 
 2 Died within first week  
 
6.11 Mode of 
delivery: 
 1 Spontaneous  4 CS elective Indication when 
caesarean section: 
Primary 
  2 Vacuum, vaginal  5 CS others Secondary 
   3 Forceps, vaginal  6 Assisted breech 6.12 Failed intervention  1 Vacuum 
      7 Destructive operative   2 Forceps 
 6.13 Does the child have 
any of these 
conditions? 
 1 Birth defects 
  2 Injuries 
  3 Diseases 
 4 HIV Positive 
 




Date of delivery 
 
 
 6.3 Sex  1 Male 6.4 Birth weight 
(gram)      2 Female  
6.2 Time of delivery    3 Unknown, unspec. 6.5 Length 6.6 Head  
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          (cm)  Circum 
6.7 Presentation:  1 Cephalic 6.8 Status  1 Live born 
   2 Breech   2 Live born transferred to paediatrics dept 
   3 Transverse   3 Stillborn Cause of death 
   4 Other   4 Neonatal death  
 
6.9 If stillborn:  1 Dead before labour  If stillborn, also specify: And: Post mortem: 
   2 Dead during labour   1 Dead before admission  1 Fresh  1 Yes   
   3 Unknown, unspec.   2 Dead after admission  2 Macerated  2 No   
 
6.10 Apgar 
score:   
1min 5 min 10 min 
If neonatal 
death: 
 1 Died within first 24 hours Date of death: 
 2 Died within first week  
 
6.11 Mode of 
delivery: 
 1 Spontaneous  4 CS elective Indication when 
caesarean section: 
Primary 
  2 Vacuum, vaginal  5 CS others Secondary 
   3 Forceps, vaginal  6 Assisted breech 6.12 Failed intervention  1 Vacuum 
      7 Destructive operative   2 Forceps 
 6.13 Does the child have 
any of these 
conditions? 
 1 Birth defects 
  2 Injuries 
  3 Diseases 
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